Qmed Asia
PrivateLast Round
Crowdfunding
Apr 5, 2023
Est. Valuation
$23.77M
Total Funding Raised
$1.63M
Company Overview
Qmed Asia operates in Healthcare & Life Sciences and is based in Kuala Lumpur. Its latest recorded funding round was a Crowdfunding round in April 2023.
Qmed Asia is a health-tech company that provides a comprehensive suite of SaaS solutions for healthcare providers, including appointment booking, mobile queuing systems, teleconsultations, and AI-powered clinical assistants.
Sector
Healthcare & Life Sciences
Verticals
EHR & EMR, Telemedicine, Medical AI, Patient Engagement, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Hardware + Subscription, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qmed Asia Comparables
Compare Qmed Asia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Invitrace Company Limited | 81% | |
| Bot MD | 80% | |
| Heals Healthcare | 79% |
For institutional investors. Book with your work email.
Qmed Asia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Apr 5, 2023 | ||||
| Angel | Dec 31, 2021 | ||||
| Grant | Dec 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Qmed Asia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 1337 Ventures | Crowdfunding |
| Cradle Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 31, 2021
$360K raised in an angel round.
- Dec 1, 2021
$108K grant received from Cradle Fund.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withAug 11, 2026
On Aug 7th '26, Qmed and Intel Corporation partner to develop a unified patient monitoring system that improves patient monitoring and clinical workflows in hospitals across Malaysia.
For institutional investors. Book with your work email.
Qmed Asia Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Qmed Asia's valuation, stock price, and market status.
Is Qmed Asia a public or private company?
Qmed Asia is a private company.
What is the current stock price of Qmed Asia?
Qmed Asia is a private company, so its shares have no public market price. Caplight tracks Qmed Asia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Qmed Asia worth (valuation)?
Qmed Asia's valuation is estimated at $23.8M based on funding round data.
Can I buy Qmed Asia stock?
Qmed Asia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Qmed Asia's last funding round?
Qmed Asia's most recent funding round was Crowdfunding on April 5, 2023.
Who are the main investors in Qmed Asia?
Key investors in Qmed Asia include 1337 Ventures, Cradle Fund.
Will Qmed Asia IPO soon?
No public IPO plans have been announced for Qmed Asia.
How can I track Qmed Asia secondary market activity?
Caplight tracks bids, offers, and trades in Qmed Asia's shares on secondary markets.